RE: 250p to 300p very short term.... 700p plus within this year.13 Jan 2021 07:05
Dr. Graham stated: "I am excited to join Tiziana to help develop its unique monoclonal antibody platform for autoimmune diseases. Tiziana's ability to deliver antibody immunotherapeutics via oral and nasal routes is a potential game-changer for patients and physicians alike".